RESPIRATORY SYNCYTIAL VIRUS IMMUNIZATION
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS IMMUNIZATION explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS IMMUNIZATION trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS IMMUNIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mRNA RSV vaccine shows promise in early trial
⭐️ VACCINE ⭐️ CompletedThis study tested different versions of an mRNA vaccine for RSV (a common respiratory virus) in 240 healthy adults aged 18 to 49. The goal was to check safety and how well the vaccines trigger an immune response. Each participant received one shot and was followed for about 6 mon…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS IMMUNIZATION
Phase: PHASE1 • Sponsor: Sanofi • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 13:52 UTC
-
New RSV shots slash baby hospitalizations in landmark study
Prevention CompletedThis study checked if new RSV prevention medicines given to babies and pregnant women reduced hospital stays for young children. Researchers looked at health records of nearly 2,800 kids under 2 in Australia. The goal was to see if the 2025 prevention program lowered RSV-related …
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS IMMUNIZATION
Sponsor: Nicola Irwin • Aim: Prevention
Last updated May 22, 2026 14:02 UTC